Welcome to our dedicated page for Senseonics SEC filings (Ticker: SENS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking how Senseonics finances next-generation Eversense implants isn’t simple—its 10-K spreads clinical-trial data, FDA milestones, and convertible-note terms across 200+ pages, while each quarterly 10-Q reshapes gross-margin outlooks. Investors asking “What does Senseonics report in their SEC filings?” or searching for “Senseonics insider trading Form 4 transactions” often face dense medical-device language that slows decisive action.
Stock Titan removes that friction. Our AI reviews every Senseonics annual report 10-K simplified, each Senseonics quarterly earnings report 10-Q filing, and all Senseonics 8-K material events explained, then delivers clear, plain-English summaries. Need “Senseonics Form 4 insider transactions real-time”? You’ll get instant alerts the second an executive files. It’s the fastest route for understanding Senseonics SEC documents with AI-driven clarity—no footnote digging required.
We connect filing types to the factors that truly drive this med-tech innovator. Use the 10-K and 10-Q to trace Eversense production costs, partnership revenue with Ascensia, and risk factors tied to long-term sensor accuracy. Dive into the proxy statement executive compensation section to see how milestone-based bonuses align with FDA approvals. Monitor executive stock transactions Form 4 to gauge insider confidence, and compare data across quarters with our “Senseonics earnings report filing analysis” tool. Whether you’re modeling cash burn or evaluating dilution, Stock Titan’s AI-powered summaries, real-time updates, and complete coverage make Senseonics SEC filings explained simply.
Senseonics Holdings (SENS) approved a 1-for-20 reverse stock split and reduced authorized common shares to 70,000,000. The action is set by a Certificate of Amendment and becomes effective at 4:05 p.m. Eastern Time on October 17, 2025. At the effective time, every twenty issued and outstanding common shares will be combined into one share, with no change to par value.
The split triggers proportional adjustments to outstanding stock options, restricted stock units, warrants, and the share reserves under equity plans. Fractional shares will not be issued; stockholders otherwise entitled to a fraction will receive a cash payment instead. The reverse split applies to all holders proportionately and does not change any holder’s ownership percentage, aside from effects related to fractional shares. The common stock is expected to begin trading on a split-adjusted basis on the NYSE American on October 20, 2025 under the symbol SENS.
Senseonics Holdings director Douglas S. Prince received 19,673 shares of common stock on 10/01/2025 as payment under the company’s non-employee director compensation policy in lieu of quarterly retainer fees. The shares were issued using the closing price of $0.413 on the NYSE American for that date, representing the reported cash-equivalent value of $8,124.95. After the issuance, the filing reports the reporting person beneficially owned 1,107,280 shares. The Form 4 was signed by an attorney-in-fact and filed on 10/03/2025.
Douglas A. Roeder, a director of Senseonics Holdings, Inc. (SENS), received 35,714 shares of common stock under the company’s non-employee director compensation policy in lieu of quarterly cash retainer fees. The shares were issued based on the NYSE American closing price of $0.413 per share on the transaction date, representing cash-equivalent compensation of $14,749.88. After this issuance, the reporting person beneficially owned 1,694,540 shares of the issuer’s common stock. The transaction is reported on a Form 4 and was filed by a single reporting person. The Form states the issuance was pursuant to the issuer’s director compensation policy and discloses the calculation used to determine the share amount.
Senseonics Holdings director Edward Fiorentino received 34,200 shares of common stock on 10/01/2025 under the company's non-employee director compensation policy. The shares were issued in lieu of a quarterly retainer; the filing states the number of shares equals $14,124.60 divided by the closing price of $0.413 per share on the NYSE American that day.
After the issuance, the reporting person beneficially owned 1,379,301 shares. The Form 4 was signed by attorney-in-fact Frederick T. Sullivan on 10/03/2025. The filing records this as a routine equity grant to a director under the disclosed compensation policy.
Senseonics Holdings, Inc. disclosed an insider transaction on a Form 4 showing a director received 31,174 shares of common stock on October 1, 2025. The shares were issued under the non-employee director compensation policy in lieu of quarterly retainer fees, calculated as $12,874.86 divided by the $0.413 closing price on that date.
Following the transaction, the director beneficially owned 1,294,175 shares, held directly.
Senseonics Holdings, Inc. (SENS) is asking shareholders to approve authority for its board to implement a reverse stock split at a ratio between 1-for-10 and 1-for-20, at any time before September 29, 2026. The Special Meeting will be held virtually on September 29, 2025 and the record date is August 7, 2025 when 814,680,910 shares were outstanding. The board unanimously recommends a vote FOR the proposal to give management flexibility to raise the per-share trading price, address NYSE American minimum price criteria, potentially improve marketability and liquidity, and preserve flexibility for future corporate actions. No fractional shares will be issued; holders entitled to fractions will receive cash based on the five-day average closing price before the effective date. Approval requires a majority of votes properly cast.
Senseonics Holdings, Inc. reported that Robert J. Smith and affiliated entities beneficially own a combined 50,035,000 shares of common stock, equal to 6.14% of the class. That aggregate position is composed of holdings by Energy Capital, LLC (49,700,000 shares, 6.10%) and Plato & Associates, LLC (335,000 shares, 0.04%).
The filing states Mr. Smith has sole voting and sole dispositive power over the reported shares, meaning he alone can direct voting and disposition of the position. The statement includes a certification that the securities were not acquired to change or influence control of the issuer.
FAQ
What is the current stock price of Senseonics (SENS)?
What is the market cap of Senseonics (SENS)?
